AP NEWS

Global Pancreatic Cancer Therapeutics Market (2019-2023): Expected to Exceed a CAGR of 8% - ResearchAndMarkets.com

January 23, 2019

DUBLIN--(BUSINESS WIRE)--Jan 23, 2019--The “Global Pancreatic Cancer Therapeutics Market 2019-2023” report has been added to ResearchAndMarkets.com’s offering.

The pancreatic cancer therapeutics market will register a CAGR of more than 8% by 2023.

Availability of improved diagnostic modalities to drive growth in the market

To combat the shortcomings in the prognosis of pancreatic cancer, advanced diagnostic aids based on the principles of complementary DNA (cDNA) fingerprinting, PCR, and DNA microarray, and molecular profiling are being developed.

Robust pipeline and new drug approvals

The pipeline for the treatment of pancreatic cancer includes novel therapeutic approaches, including vaccines, gene therapy, stem cell therapy, and targeted therapy products.

High cost of treatments

Pancreatic cancer requires long term treatment, which increases the treatment cost and the economic burden on patients.

Key Players

Eli Lilly F. Hoffmann-La Roche Novartis Pfizer Shire

Topics Covered

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: MARKET LANDSCAPE

PART 04: PIPELINE ANALYSIS

PART 05: MARKET SIZING

PART 06: FIVE FORCES ANALYSIS

PART 07: MARKET SEGMENTATION BY PRODUCT

Comparison by product Targeted therapy - Market size and forecast 2018-2023 Chemotherapy - Market size and forecast 2018-2023 Market opportunity by product

PART 08: CUSTOMER LANDSCAPE

PART 09: MARKET SEGMENTATION BY TYPE

Exocrine pancreatic cancer Endocrine pancreatic cancer

PART 10: GEOGRAPHIC LANDSCAPE

Geographic comparison Americas - Market size and forecast 2018-2023 EMEA - Market size and forecast 2018-2023 APAC - Market size and forecast 2018-2023 Key leading countries Market opportunity

PART 11: DRIVERS AND CHALLENGES

PART 12: MARKET TRENDS

PART 13: VENDOR LANDSCAPE

PART 14: VENDOR ANALYSIS

Vendors covered Vendor classification Market positioning of vendors Eli Lilly F. Hoffmann-La Roche Novartis Pfizer Shire

For more information about this report visit https://www.researchandmarkets.com/research/6s4d5h/global_pancreatic?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20190123005456/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Pancreatic Cancer Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH ONCOLOGY PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 01/23/2019 08:27 AM/DISC: 01/23/2019 08:27 AM

http://www.businesswire.com/news/home/20190123005456/en

AP RADIO
Update hourly